Follow The Filings

RVMD position history

The shares of Revolution Medicines (RVMD) that Opaleye Management Inc. reported in each quarter’s 13F.

Equity, COM

Shares held by quarter

New Add Reduce Exit

  1. 2025 Q2: 210,000 shares, $7.7M, 1.6% of portfolio, New
  2. 2025 Q3: 100,000 shares, $4.7M, 0.66% of portfolio, Reduce −52.4%
  3. 2025 Q4: 200,000 shares, $16M, 2.1% of portfolio, Add +100.0%
  4. 2026 Q1: 100,000 shares, $9.7M, 1.3% of portfolio, Reduce −50.0%
  5. 2026 Q2: 100,000 shares, $19M, 1.7% of portfolio
Holdings date Value % of holdings Shares Filing date All 13F holders